GenLight Medical raises several hundred million yuan across C and D rounds
What's the deal? GenLight Medical has closed consecutive Series C and Series D rounds, raising several hundred million yuan in total. Qiming Venture Partners led the C round, while the D round drew Saizhi Bole, Kuanqiao Hengsong, Ningbo state capital, and other investors.
What's the endgame? The company builds implantable neurostimulation technology. It plans to use the funds to advance registration and commercialisation of its Epilcure system for drug-resistant focal epilepsy.
Why now? GenLight is also pushing the clinical translation of its Vivastep spinal interface, alongside regulatory filings and clinical collaborations overseas. The dual raise gives it capital to move both products toward market at once.
The signal: Back-to-back rounds from a mix of venture and state-backed investors point to sustained appetite for China's implantable medical device sector — and to companies positioning themselves for expansion beyond home markets.
Read more: technode.com
Image credit: Generated with Gemini
